COV:CA Stock

On Oct. 21, Research Capital analyst Andre Uddin reaffirmed his “Buy” rating and C$3.75 target p... Read More

Research Capital analyst Andre Uddin maintained a “Buy” rating and $3.75 target for Covalon Tech... Read More

Research Capital analyst Andre Uddin likes what he sees from Covalon Technologies (Covalon Technolog... Read More